Mynox® is an antibiotic-free formulation for mycoplasma eradication from cell cultures. Its activity is based on a biophysical mechanism, which therefore does not enable the development of resistant strains.
Mynox® is intended for research use only. Not applicable for clinical treatment. Protocols for the direct treatment of viruses are described in the product manual.
Mynox® is a sterile, ready-to-use solution, aliquoted per tube for single use, 200 µl per vial.
1 application can be used to permanently eliminate mycoplasma from one cell culture.
- Cat. No. 10-0200 2 applications
Cat. No. 10-0500 5 applications
Cat. No. 10-1000 10 applications
Successful elimination of mycoplasma should be verified with a suitable mycoplasma detection system, e.g. Minerva Biolabs’s Venor®GeM Mycoplasma PCR Detection Kits.
Tissue culture petri dish (60 mm Ø)
Regular cell culture plastics
Required Lab Devices
Regular cell culture equipment (incubator, centrifuge, pipettes, etc.)
Shelf Life and Storage
Kit components are maintainable at +2 to +8 °C for at least 6 months.
Fig. Electron micrograph showing the effects of Mynox® when applied to contaminated cell cultures. (A) Mycoplasma contaminated cell culture before treatment. (B) With one application of Mynox® membranes of all mycoplasma are destroyed while the tissue cell membrane is unaffected. Black arrows indicate mycoplasmas, white arrows indicate parts of a tissue cell.